[ad_1]
Article content material continued
The estimated 400 new circumstances symbolize a couple of 4.9 per cent positivity price, Alberta’s lowest worth since Oct. 31. Over the previous week, the province’s take a look at positivity price has hovered between about seven and eight per cent.
Read extra.
U.S. could lower some Moderna vaccine doses in half to hurry rollout, official says
The U.S. authorities is contemplating giving some folks half the dose of Moderna’s COVID-19 vaccine in an effort to velocity vaccinations, a federal official stated on Sunday.
Moncef Slaoui, head of Operation Warp Speed, the federal vaccine program, stated on CBS’ “Face the Nation” that officers have been in talks with Moderna and the Food and Drug Administration concerning the thought. Moderna’s vaccine requires two injections.
“We know that for the Moderna vaccine, giving half of the dose to people between the ages of 18 and 55, two doses, half the dose, which means exactly achieving the objective of immunizing double the number of people with the doses we have,” Slaoui stated.
“We know it induces identical immune response” to the complete dose, he added.
Moderna and the FDA couldn’t instantly be reached for remark.
Read extra.
Tougher lockdown restriction possible on the way in which, says UK PM Johnson
LONDON — British Prime Minister Boris Johnson stated on Sunday that harder lockdown restrictions have been in all probability on the way in which as COVID-19 circumstances preserve rising, however that faculties have been protected and youngsters ought to proceed to attend.
Cases of COVID-19 in Britain are at document ranges and growing, fueled by a brand new and extra transmissible variant of the virus. That has already pressured the federal government to cancel the deliberate reopening of colleges in and round London, with calls from instructing unions for wider closures.
Much of England is already beneath the hardest stage of restriction set out in a four-tier system of regional laws designed to cease the unfold of the virus and shield the nationwide healthcare system.
Read extra.
India’s approval of homegrown vaccine criticized over lack of information
NEW DELHI — India on Sunday granted emergency approval to Bharat Biotech’s COVAXIN however confronted questions from trade consultants and opposition lawmakers after taking the step with out publishing efficacy knowledge for the homegrown coronavirus vaccine.
Read extra.
[ad_2]
Source link
